Vertex, Inc. (NASDAQ: VERX) — the tax technology company (not Vertex Pharmaceuticals, which trades as VRTX) — is back on investors’ radar on Tuesday, December 16, 2025, as shares trade higher intraday and the market continues to digest a year defined by two big themes: cloud migration and a rapidly expanding AI-driven product strategy.

As of midday Tuesday, VERX traded at about $20.48, up roughly 5% on the session, after opening near $19.40 and moving between roughly $19.24 and $20.51 with under 1 million shares traded at the time of the snapshot. ^[1]

That price action is notable mostly because it’s happening against a backdrop of mixed growth signals: Vertex is still delivering double-digit revenue expansion and strong cloud…